EPCO-17. UNMASKING CLONAL EVOLUTION OF DIFFUSE INTRINSIC GLIOMA USING MULTI-MODAL GENOMIC DATA
نویسندگان
چکیده
Abstract Diffuse intrinsic pontine glioma (DIPG) is an infiltrative incurable tumor affecting children. DIPG tumors often harbor a recurrent H3K27M mutation which leads to global loss of H3K27me2/3 and overall DNA hypomethylation, suggesting important role the epigenome, consequent transcriptome in pathogenesis. To thoroughly characterize clonal evolution DIPG, we collected 33 samples from 7 patients using multi-region sampling strategy generated whole-exome sequencing, methylation profiling data. Using our novel bioinformatics approach, 28 distinct sub-clones were identified characterized cohort whilst simultaneously interrogating tumor’s ability migrate disseminate. When present, initiating clone (Clone 1) exclusively contained with significant changes whereas divergent clones that arise later evolutionary trees typically driven by copy number aberrations. Further characterization unique gene expression profiles (i.e. cell migration angiogenesis programs) support enable dissemination. In this study, uncovered how evolves at genetic, epigenetic, transcriptional levels parallel doing so, reveal phenotypes sub-clonal level related behavior. We are further validating these results single-cell RNA sequencing experiments gaining insights into underlying molecular mechanisms responsible for invasive aggressive phenotypes.
منابع مشابه
Genomic Insights into Diffuse Intrinsic Pontine Glioma
Diffuse intrinsic pontine glioma (DIPG) is a highly aggressive pediatric brainstem tumor with a peak incidence in middle childhood and a median survival of less than 1 year. The dismal prognosis associated with DIPG has been exacerbated by the failure of over 250 clinical trials to meaningfully improve survival compared with radiotherapy, the current standard of care. The traditional practice t...
متن کاملNanotechnology Applications for Diffuse Intrinsic Pontine Glioma
Diffuse intrinsic pontine gliomas (DIPGs) are invariably fatal tumors found in the pons of elementary school aged children. These tumors are grade II-IV gliomas, with a median survival of less than 1 year from diagnosis when treated with standard of care (SOC) therapy. Nanotechnology may offer therapeutic options for the treatment of DIPGs. Multiple nanoparticle formulations are currently being...
متن کاملClonal Genomic Alterations in Glioma Malignancy Stages1
Comparison of constitutional and tumor genotypes at chromosomal loci defined by restriction fragment length alÃ-eleshas proven useful in determining the genomic position and tissue specificity of recessive mutations that predispose to cancer (Hansen, M. F., and Cavenee, W. K. Cancer Res., 47:5518-5527,1987). Here we have applied this approach to 53 unrelated patients with glial tumors of varyin...
متن کاملDiffuse intrinsic pontine glioma: poised for progress
Diffuse intrinsic pontine gliomas (DIPGs) are amongst the most challenging tumors to treat. Surgery is not an option, the effects of radiation therapy are temporary, and no chemotherapeutic agent has demonstrated significant efficacy. Numerous clinical trials of new agents and novel therapeutic approaches have been performed over the course of several decades in efforts to improve the outcome o...
متن کاملTranscriptional Dependencies in Diffuse Intrinsic Pontine Glioma.
Diffuse intrinsic pontine glioma (DIPG) is a fatal pediatric cancer with limited therapeutic options. The majority of cases of DIPG exhibit a mutation in histone-3 (H3K27M) that results in oncogenic transcriptional aberrancies. We show here that DIPG is vulnerable to transcriptional disruption using bromodomain inhibition or CDK7 blockade. Targeting oncogenic transcription through either of the...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Neuro-oncology
سال: 2022
ISSN: ['1523-5866', '1522-8517']
DOI: https://doi.org/10.1093/neuonc/noac209.452